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ABSTRACT 
Obesity and dyslipidaemia are features of the metabolic syndrome and risk factors for chronic kidney 
disease. The cellular mechanisms connecting metabolic syndrome with chronic kidney disease onset 
and progression remain largely unclear. We show that proximal tubular epithelium is a target site for 
lipid deposition upon overnutrition with a cholesterol-rich Western-type diet. Affected proximal 
tubule epithelial cells displayed giant vacuoles of lysosomal or autophagosomal origin, harbouring 
oxidized lipoproteins and concentric membrane layer structures (multilamellar bodies), reminiscent 
of lysosomal storage diseases; lipidomic analysis revealed renal deposition of cholesterol and 
phospholipids, including lysosomal phospholipids. Proteomic profiles of renal multilamellar bodies 
were distinct from those of epidermis or lung multilamellar bodies and of cytoplasmic lipid droplets. 
Tubular multilamellar bodies were observed in kidney biopsies of obese hypercholesterolaemic 
patients, and the concentration of the phospholipidosis marker di-docosahexaenoyl (22:6) 
bis(monoacylglycerol) phosphate was doubled in urine from individuals with metabolic syndrome 
and chronic kidney disease. The enrichment of proximal tubule epithelial cells with phospholipids 
and multilamellar bodies was accompanied by enhanced inflammation, fibrosis, tubular damage 
markers and higher urinary electrolyte content. Concomitantly to the intralysosomal lipid storage, a 
renal transcriptional response was initiated to enhance lysosomal degradation and lipid synthesis. In 
cultured proximal tubule epithelial cells, inhibition of cholesterol efflux transport or oxysterol 
treatment induced effects very similar to the in vivo situation, such as multilamellar body and 
phospholipid amassing, and induction of damage, inflammatory, fibrotic and lipogenic molecules. 
Onset of phospholipidosis onset in proximal tubule epithelial cells is a novel pathological trait in 
metabolic syndrome-related chronic kidney disease, and emphasizes the importance of healthy 
lysosomes and nutrition for kidney wellbeing.  
This article is protected by copyright. All rights reserved.
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Introduction 
In the current obesity epidemic, increasing attention has been given to the obesity-related diseases, 
atherosclerosis, diabetes and metabolic syndrome (MetS). Emerging evidence indicates that MetS 
individuals are prone to chronic kidney diseases (CKD) and end-stage renal diseases (ESRD). A 
systematic meta-analysis based on 25 general population cohort studies demonstrates that obesity 
confers a significantly higher risk of kidney disease compared to normal-weight individuals [1]. In 
addition, two large cohort studies in Japan and in the United States linked an increased risk for ESRD 
with high body-mass index (BMI) [2, 3] independently of hypertension and diabetes [2-6]. 
Remarkably, visceral obesity also puts lean subjects at risk of CKD [7, 8]. The association between 
MetS and CKD becomes particularly relevant in renal transplantation, as MetS appearance adversely 
affects allograft survival and long-term function [9]. 
Despite such associations between MetS and CKD, the etiological role of MetS and obesity in CKD 
development and progression remains unclear, due to the complexity and bidirectionality of the 
relationship between the two medical conditions [10]. Nevertheless, the description of ectopic fat 
deposition in kidneys and the strong interrelation between obesity (particularly BMI) and ESRD 
suggest a role for fat accumulation per se in the initiation of renal dysfunction or in the progression 
of existing renal disease [11, 12]. Several studies indeed hint at a causal relationship: (a) weight loss 
ameliorates proteinuria in overweight patients affected by chronic proteinuric nephropathies; (b) the 
rates of allograft dysfunction and acute rejection episodes are higher for obese living kidney donors; 
(c) inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), the rate-limiting 
enzyme in cholesterol biosynthesis, improves proteinuria and reduces renal function loss; (d) low-
carbohydrate and low-fat diets exert beneficial effects on renal function in obese individuals [13-17]. 
Altogether, these reports strongly indicate a lipid-mediated effect in initiating renal dysfunction or 
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injury. In this regard, most of the lipotoxic effect of renal lipid overload linked to obesity and MetS 
and kidney dysfunction has been attributed to renal steatosis through free-fatty acid (FFA) and 
triglyceride (neutral lipids) accumulation within cytoplasmic lipid droplets (LDs) [12, 18, 19]. Here, we 
report the accumulation of free cholesterol (FC) and phospholipids (polar lipids) within multilamellar 
organelles of lysosomal origin (phospholipidosis) inside renal proximal tubular epithelial cells (PTEC) 
following Western-diet (WD) feeding. A similar excessive storage of complex polar lipids has been 
disclosed in PTEC in lysosomal storage diseases, caused by defects in lysosomal lipases or lysosomal 
lipid transport proteins [20]. 
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Material and Methods 
Animal studies  
Male wild-type C57BL/6 mice (Charles River) were subjected to control diet (4021.84, AB Diets), 
Western diet (4021.83, AB Diets) or water enriched with 15% (w/v) fructose (Sigma Aldrich) ad 
libitum for 16 weeks [21]. GFP-LC3 transgenic mice [22, 23] were fed Western diet. Kidneys from 
Npc1nih/nih, Glatm1Kul/Y, ob/ob mice and 88-week-old mice were used for transmission electron 
microscopic (TEM) imaging [24-27]. All procedures were approved by the Animal Care and Use 
Committee of the Academic Medical Center Amsterdam. 
Cell culture and isolation of multilamellar bodies (MLBs) 
HK2 and IMM-PTEC were cultured in DMEM/F12 supplemented with ITSe, triiodothyrionine, 
hydrocortisone and prostaglandin E1 (Sigma-Aldrich), plus interferon-ϒ for IMM-PTEC (PROSPEC) 
[28]. MLBs were isolated by homogenization and sucrose gradient fractionation; MLBs were 
recovered at the interface between 0.4 M and 0.35 M sucrose. Urine MLBs were purified by 
ultracentrifugation [29]  
Lipidomics and proteomics 
Lipids were isolated by chloroform/methanol extraction and quantified by ESI-MS/MS [30-32]. 
Sphingolipids were butanol-extracted and analysed by LC-MS/MS [33-35]. GC-MS Solution Software 
was used for data acquisition and processing [36]. Urine di-docosahexaenoyl (22:6) 
bis(monoacylglycerol) phosphate (di-22:6-BMP) content was determined by HPLC-MS [37, 38].  
For LC-MS proteomics, samples were denatured and digested, following by Nanoscale LC separation 
of tryptic peptides. MS data were acquired in triplicate in ion mobility enabled data independent 
analysis mode [39] using a Synapt G2-Si instrument (Waters Corporation). ISOQuant was applied for 
integrated quantitative analysis of data from multiple LC-MS [40, 41]. Reactome, BLAST2GO, GO 
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terms and KEGG pathway annotation analyses were used for pathway/gene ontology annotation [42-
44]. 
Patient study  
Urine samples belong to the TransplantLines cohort (ClinicalTrials.gov Identifier: NCT02811835, 
University Medical Center Groningen, The Netherlands) [45-48] Control samples were obtained from 
transplant donors and the disease group was selected on basis of CKD clinical diagnosis and presence 
of clinical parameters matching MetS World Health Organization criteria (hypertension, BMI, plasma 
cholesterol and triglycerides). The transmission electron microscopy (TEM) images shown in 
supplementary material, Figure S5 were selected from screening 69 biopsies of nephrotic syndrome 
patients from the University Hospital of Nijmegen, The Netherlands; the images of Figure 5E are 
derived from obese hypercholesterolaemic patient renal biopsies collected at the Academic Medical 
Center of Amsterdam, The Netherlands. 
Statistics 
Statistics was performed using One-Way ANOVA and Dunnett’s tests; Mann-Whitney U test and 
Spearman rank correlation. Data are presented as mean and SEM; p < 0.05 was considered 
significant. 
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Results 
Accumulation of polar lipids/phospholipids and free-cholesterol in murine proximal tubular 
epithelial cells upon Western-type diet feeding 
Feeding mice for 16 weeks a Western-type diet (WD) containing 0.15% cholesterol and providing 43% 
energy from fat vs. a control diet (CD), in which 11% of energy comes from fat, leads to a prominent 
cytoplasmic vacuolization of renal tubular epithelial cells (Figure 1A,B). In all kidneys from WD-fed 
mice, the vacuoles were located in the proximal tubules S2/S3 segments (not in S1) and absent in 
distal tubular, endothelial or glomerular cells (Figure 1A, and supplementary material, Figure S1A). By 
staining kidney sections for the lipid droplet marker perilipin-2 [49, 50], we found numerous small 
LDs along the tubular cell basolateral membrane after WD-feeding; however, the large, more apically 
located, vacuoles were all negative for perilipin-2 (Figure 1C). Remarkably, these vacuolized tubules 
were enriched in phospholipids and free-cholesterol, as shown by Nile red and filipin staining, 
respectively (Figure 1D,E). Accordingly, quantitative lipidomics analysis of renal tissues from mice 
subjected to WD revealed an increase in several lipids, including free-cholesterol (FC), fatty acids 
(FA), several phospholipids and sphingolipids (Figure 1F). 
As human studies showed that obesity increases the incidence of a distinct obesity-related 
glomerulopathy (ORG) [51-53], the extent of glomerular lesions (mesangial cell proliferation, 
mesangial matrix expansion and mesangiolysis) after WD feeding was evaluated. However, no 
significant alterations were observed in the glomerular compartment between CD and WD groups 
(supplementary material, Figure S1B). Thus, although kidneys are generally regarded as non-highly 
active metabolic organs, we show that tubular epithelial cells are sites of profound lipid deposition 
within large vacuoles during lipid overnutrition. 
Features of acquired lysosomal storage disease in kidneys exposed to lipid overloading 
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Transmission electron microscopy revealed that these tubular vesicles contained lots of concentric 
thin electron-dense lamellae surrounded by a limiting membrane (Figure 2A). These structures 
reached a maximum diameter of 8-9 µm and ultrastructurally resembled the multilamellar bodies 
(MLBs) that we and others found in kidneys from mice with lysosomal storage diseases such as Fabry 
and Niemann-Pick type C [24, 54] (supplementary material, Figure S2A). In line with studies 
associating aging with lysosomal impairment [55], aged mice also presented MLBs. As after WD 
feeding, subjecting mice to high-fat diet (HFD) resulted in MLB formation in PTEC (supplementary 
material, Figure S2A). In contrast, leptin-deficient (ob/ob) mice on a regular diet and Wt mice given 
ad libitum water enriched with 15% fructose for 16 weeks have hardly any renal MLBs 
(supplementary material, Figure S2B, S2C). This implies that the massive expansion of MLBs in PTEC is 
a specific reaction to excessive dietary lipid intake, and not generally to any kind of overnutrition. 
Next, we discovered that lysosomal and autophagy markers, LIMP-2, CD63, p62 and LC3 [56], were 
present in the vacuole delimiting zone in WD-PTEC (Figure 2A,B). To directly monitor autophagy, 
GFP-LC3 transgenic mice were fed a WD for 16 weeks; we found that both LIMP-2 and GFP-LC3 co-
localized at the vacuole limiting membrane and Western diet dramatically increased renal GFP-LC3 
puncta formation (Figure 2C). This suggests a lysosomal/autophagic origin (autolysosomes) [57] of 
renal diet-induced MLBs, similarly to what is described in lysosomal storage diseases [20]. 
We next used laser-capture microdissection (LCM) technology to obtain a histologically pure cell 
population enriched in vacuolized PTEC for RNA transcript profiling. The expression of lysosome- and 
lipid metabolism-associated genes was enhanced in response to high-fat/cholesterol feeding in 
vacuolized proximal tubules (Figure 2D). Indeed, the transcription of genes encoding LIMP-2 and the 
master regulator of lysosomal function transcription factor EB (TFEB) showed a trend towards 
increased expression upon overnutrition (p = 0.057) and the gene expression of the lysosomal 
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enzymes acid ceramidase Asah1 (N-acylsphingosine amidohydrolase 1) and acid sphingomyelinase 
Spmd1 (sphingomyelin phosphodiesterase 1) was significantly upregulated in WD-vacuolized tubules 
[58, 59]. Furthermore, the lipogenic transcription factors sterol regulatory element-binding protein 2 
and 1c (Srebp2, Srebp1c) and their target genes Ldlr (low-density lipoprotein receptor) and Fas (fatty 
acid synthase), respectively, were strongly induced in lipid-enriched tubules [60, 61] (Figure 2D). 
Altogether, our findings disclose the importance of tubular lysosomes in the renal response to WD 
feeding and the acquisition of a “lysosomal storage disease phenotype” in PTEC upon diet-derived 
lipid overload. 
Finally, we found that renal MLB formation is likely to be driven by lipoprotein uptake, since WD-
induced renal vacuoles harbour lipoproteins, including oxidized lipoproteins, and LDLR (Figure 2E). 
Renal and urinary MLBs have a unique proteomic footprint 
As MLBs from other organs are known to be released into the extracellular space [54], we wondered 
whether MLBs could be secreted by PTEC. MLBs can be detected by TEM in urine of mice fed a WD 
(Figure 3A). In addition, immortalized proximal tubular epithelial cells (IMM-PTEC) secreted 
extracellular vesicles in a lysosomal storage disease-like state, as proven by the detection of the 
flotillin-2 extracellular vesicle marker [62] in the supernatant of IMM-PTEC treated with U18666A, an 
inhibitor of cholesterol trafficking out of lysosomes, largely used to reproduce in vitro the NPC1 
disease [63-65] (Figure 3B). 
To better characterize MLBs, proteomic analysis was performed on MLBs isolated from kidneys and 
urine of WD-fed mice or U18666A-stimulated IMM-PTEC (supplementary material, Figure S3A-C). We 
identified 526 proteins (supplementary material, Excel spreadsheet S1); Figure 3C shows the most 
abundant proteins detected in kidneys, urine and IMM-PTEC upon metabolic overloading. Many of 
these proteins have been identified as located within extracellular exosomes, and some, such as 
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GGT1 (gamma-glutamyltransferase 1), ATPA1 (ATPase, Na+/K+ transporting, alpha 1 polypeptide), 
and ALDOB (aldolase B, fructose-bisphosphate) have high (though not exclusive) renal expression, 
(www.ncbi.nlm.nih.gov/gene). In addition, kidney MLBs express proteins involved in lipid cellular 
uptake and trafficking, such as megalin [66, 67], sterol carrier protein 2 (SCP2) [68, 69], Hsp90 [70], 
legumain (LGMN) [71], Na+/H+ exchange regulatory cofactor 3 (NHRF3) [72], and fatty acid-binding 
proteins (FABPs), albumin and apolipoprotein E [73]. 
Proteomics also revealed the presence of lysosomal proteins and proteins normally located in other 
organelles and cellular compartments, such as cytoskeleton, mitochondria and plasma membrane 
(Figure 3D and supplementary material, Figure S4). Reactome pathway-based analysis show that 
metabolism-related pathways are among the most enriched pathways (supplementary material, 
Figure S3D, highlighted in yellow) associated with the MLB proteome. This is in line with the known 
lysosomal functions in cellular clearance and nutrient/energy sensing [74, 75] and the above 
described data indicating that lysosome-derived MLBs are part of a metabolic cellular adaptation to 
lipid overload. 
It is to be noted that we used a common organelle isolation procedure based on gradient-density 
centrifugation, as employed by others for MLB isolation [76, 77]. Although this method is not 
completely contamination-free, it is the only one suitable for organelle isolation from tissues, in 
contrast to isolation from cell lines, which can be engineered to stably express a tagged organelle-
specific marker. Comparison of the renal MLB proteome with published data from proteomics of 
lysosome-related organelles (LRO), lung/epidermis-derived MLBs and lipid droplets from enterocytes, 
adipocytes or hepatocytes [76-81] revealed that renal MLBs have a unique protein profile, as shown 
by frequency/hierarchical clustering analysis (Figure 4). Indeed, most proteins were identified solely 
in renal MLBs, but not in lung/skin MLBs or LDs (supplementary material, Excel spreadsheet S2 and 
This article is protected by copyright. All rights reserved.
Table S1), indicating that they are distinct organelles. However, comparing GO annotation and 
pathways analyses of all seven sets of proteomes revealed that most of the detected proteins share 
similarities in general function such as catalytic activity and binding and participation in metabolic 
processes (supplementary material, Figure S5). 
Oxysterols and impaired cholesterol trafficking cause MLB formation, disruption of lysosome 
homeostasis and induction of cholesterogenesis genes 
By means of in vitro assays with IMM-PTEC, we demonstrate that the same multilamellar structures 
observed in vivo upon nutrient overload appear in PTECs after exposure to U18666A, oxidized LDL 
(oxLDL) and 7-ketocholesterol (7KC), which is the major oxidation product of cholesterol and among 
the most common oxysterols found in food [82] (Figure 5A). Accordingly, IMM-PTEC treatment with 
U18666A, oxLDL or 7KC elevates the intralysosomal phospholipid content and the expression of 
LIMP-2, as well as their colocalization (Figure 5B). Furthermore, oxysterols increase expression of 
both LIMP-2 and the autophagy adaptor p62 [56, 83] (Fig S2D). Altogether, the in vitro data validate 
the lysosomal origin of the MLB/vacuole organelles seen in vivo and suggest an etiological role of 
cholesterol overload in the disruption of lysosomal homeostasis. 
Since the maintenance of a proper acidic pH is fundamental for the digestion of lysosomal cargo, 
including lipids [84], we studied the lysosomal acidification rate and found that U18666A, oxLDL and 
7KC all increased lysosomal pH. Chloroquine was used as a positive control to inhibit lysosome 
acidification [85] (Figure 5C). 
Lastly, tubular phospholipidosis was accompanied by internalization of cell surface free cholesterol 
and an increase in intracellular bismonoacylglycerophosphate (BMP), an atypical phospholipid 
specific for the (endo)lysosomal compartment involved in intracellular cholesterol transport [86] 
(Figure 5D). Besides, BMP expression overlapped with the sites of phospholipidosis in U18666A-
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treated human PTECs (Figure 5E). Finally, the gene expression of Srebp2, Ldlr and Hmgcr, the rate-
controlling enzyme in cholesterol synthesis [60], were all significantly upregulated by U18666A in 
IMM-PTEC, whereas the gene expression of the lysosomal phospholipase A2 was downregulated 
(Figure 5F). 
Altogether, these data indicate that metabolic overloading of PTECs disrupts lysosomal homeostasis 
and reprograms cells towards the onset of anabolic pathways.  
Diet-mediated lipid overload of tubular cells instigates tubular damage, inflammation and collagen 
deposition in mice, and promotes formation of lipid-rich MLBs in human TECs 
To expand our view of the effects of overfeeding on kidney health and function, changes in damage, 
inflammatory and fibrotic parameters in kidneys were examined. Strikingly, after high-fat/cholesterol 
feeding, the expression of the sodium-glucose co-transporter 2 (SGLT2) at the apical membrane of 
proximal tubules almost vanished and concomitantly the proximal tubule injury marker KIM-1 
(kidney injury molecule-1) [87] was induced in PTECs.  The kidneys of WD-fed mice also show 
macrophage infiltration and collagen deposition (Figure 6A). The gene expression of Sglt2 was 
significantly diminished in WD kidneys, whereas the transcription of genes encoding MCP-1 
(monocyte chemoattractant protein-1), TGF-β (transforming growth factor-β) and CTGF (connective 
tissue growth factor) was augmented (Figure 6B). Accordingly, in vitro stimulation of IMM-PTEC with 
U18666A or 7KC provided similar results, with a reduced gene expression of the transporters Sglt2 
and Atp1a1 (ATPase Na+/K+ transporting subunit α 1) and an increased expression of Mcp1, Kim1, 
Tgfb1, Ctgf (Figure 6C). In addition, WD feeding caused higher urinary concentrations of electrolytes 
that are normally reabsorbed from the tubular lumen after glomerular filtration (Figure 6D). These 
data strongly indicate that lipid-rich diets can provoke kidney disease as tubular injury and 
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malfunction, inflammation and collagen deposition are all key features of renal dysfunction and 
pathology [88]. 
To translate our in vivo and vitro findings to human obesity-related nephropathology, kidney biopsies 
and urine samples from obese and lean individuals were used. In the presence of obesity and 
hypercholesterolaemia, human PTEC display LIMP-2-positive vacuoles, BMP accumulation and MLBs 
(Figure 6E). In addition, patients affected by nephrotic syndrome, characterized by elevated serum 
levels of total cholesterol, LDL cholesterol, and lipoprotein(a) [89], present MLBs in renal tubules 
(supplementary material, Figure S6A), emphasizing the potential role of hyperlipidaemia in kidney 
MLB genesis. MLBs were also present at the brush border of tubular cells (supplementary material, 
Figure S6B) and in the tubular lumen (supplementary material, Figure S6C), which together with the 
detection of MLBs in urine (Figure 3A), strongly suggest that MLBs are excreted by TEC into the 
urinary space. Interestingly, we also found that the urinary concentration of di-22:6-BMP, a reliable 
marker for tissue-phospholipidosis [90], is much higher in the urine of a small cohort of individuals 
affected by CKD and MetS (Figure 6F) and shows a moderate positive correlation with the total 
albumin urinary content (Figure 6G). These findings imply that renal phospholipidosis also takes place 
in humans with metabolic/lipid disorders. 
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Discussion 
Although a number of investigators have outlined the “renal lipotoxicity” hypothesis, the role of 
lipids per se as promoters of renal injury remains largely elusive and hard to prove, particularly in 
humans [91]. Altogether, our data indicate that excessive dietary lipid intake (and not overnutrition 
per se) cause the development of an “acquired lysosomal storage disease” in the kidney epithelium. 
Cholesterol/fat-rich Western diet induces large vacuoles enriched in free cholesterol, fatty acids and 
phospholipids and a robust MLB biogenesis in S2/S3 proximal tubules. Intratubular MLBs display 
lysosomal or autophagolysosomal origin and express the lysosome-bound BMP glycerolipid, 
resembling the features of lysosomal storage disease and oxLDL-loaded macrophages [54, 86]. 
Besides this, we detected MLBs in urine and found a striking excretion of the lysosomal di-22:6-BMP 
in urine of individuals affected by MetS and CKD. The lack of vacuoles, thus MLBs, in PTEC of S1 
segment can be explained by their well-developed endo-lysosomal apparatus [92] and greater 
lysosomal volume and enzymatic activity compared to S2/S3 PTEC [93-96]. 
Although we cannot completely exclude MLB leakage from damaged TEC into urine, TEC-mediated 
MLB secretion seems more likely, in light of the known MLB secretion in other organs [54] and of our 
TEM-based observations of intact MLBs within TEC brush border. Accordingly, urine and kidney MLBs 
contain identical proteins, many of which are reported to be present in exosomes, and some of the 
MLB proteins (i.e. GGT1, ATPA1, ALDOB) with the highest relative abundance are also highly 
expressed in kidneys. In addition, the identification of proteins known to participate in lipid uptake 
and lipid intracellular trafficking within kidney-derived MLB strengthen our hypothesis of 
cholesterol/lipid-driven MLB formation, e.g. megalin (receptor for albumin-FA/LDL), SCP2 
(intracellular cholesterol movement), Hsp90 (stabilization of NCP1); LGMN (lysosomal protein 
degradation), NHRF3 (maintenance of expression and function of the HDL receptor SR-BI), 
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apolipoprotein E (major cholesterol carrier), albumin and FABP suggest their uptake and 
incorporation in MLBs [66-73]. Thus, renal MLBs appear to be active organelles involved in storage of 
excessive lipids and secretion as urinary products; in kidneys, MLBs seems to act as a defence 
mechanism against lipid nephrotoxicity by sequestering and excreting surplus lipids.  
Treatment of IMM-PTEC with 7KC hydroxysterol, oxidized-LDL and cholesterol trafficking inhibitor 
U18666A provoked tubular alterations very similar to the in vivo tubular changes, suggesting an 
etiological role of oxLDL/oxysterols in the obesity-related renal disease. Indeed, WD-induced tubular 
vacuoles contained LDLR and oxidized lipoproteins, which are more abundant in obesity [97]. 
Apolipoprotein E, FABP, albumin and megalin were detected in MLBs by proteomics; thus several 
lipotoxic molecules may promote lysosomal lipid storage development in our model, besides 
oxysterols. Besides oxysterols and lipoproteins, other lipotoxic molecules may account for lysosomal 
dysfunction and lipid-rich vacuole generation in PTEC. In agreement, Kuwahara et al. attributed the 
appearance of cytosolic vacuoles in PTEC following HFD-feeding to megalin-mediated FA endocytosis 
[67]. Nevertheless, autophagy is very likely implicated in “renal lysosomal storage disease” as we 
showed with GFP-LC3 WD-fed mice; consistent with this, autophagic flux contributes to the 
physiological production of MLBs in lung type II alveolar cells [98]. Although autophagy is regarded as 
a protective mechanism that contributes to lipid catabolism by delivering LD content to lysosomes 
(lipophagy) [99, 100], the rise in lysosomal pH observed in our in vitro model may block lipophagy 
through inhibition of pH-sensitive lysosomal hydrolases. 
Interestingly and controversially, WD feeding initiated a transcriptional response in lipid-enriched 
vacuolized tubules, characterized by the up-regulation of genes accountable for lysosome biogenesis 
and function and concomitantly of genes responsible for cholesterol and FA synthesis. The enhanced 
gene expression of Tfeb itself together with Asah1 attests to TFEB activation and nuclear relocation, 
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which leads to enhance autophagic and lysosomal lipolytic processes [58, 59]. This regulation is 
probably an adaption of cells to prevent lipotoxicity; indeed, overexpression of TFEB in liver protects 
against diet-induced obesity and MetS [101]. 
The increased expression of SREBP-1/2 by dietary lipid challenge is likely to sustain intratubular lipid 
accumulation during persistent overnutrition, since they upregulate genes for FA and cholesterol 
synthesis, respectively [60]. Upon lipid overload, phospholipids and cholesterol remain engulfed in 
lysosomes; therefore, less cholesterol is likely to be transported to the endoplasmic reticulum, where 
SREBPs reside and are suppressed by the cholesterol content, as cholesterol-induced suppression of 
SREBP activation vanishes and SREBP target genes are upregulated [60, 102]. Accordingly, we showed 
that inhibition of cholesterol transport with U18666A in TEC resulted in increased transcription of 
Srebp2 and of its target genes Hmgcr and Ldlr [60, 61, 102]. 
The increased urinary electrolytes and the appearance of damage, inflammatory and fibrotic markers 
in WD-kidneys and in U18666A/7KC-treated IMM-PTEC provide an important causal link between 
kidney pathology and overnutrition. In fact, even though several epidemiological studies have proven 
a significant association of kidney dysfunction with obesity, dyslipidaemia and high BMI [2, 6, 103, 
104], a direct detrimental impact of overnutrition and excessive metabolic loading of kidney cells on 
kidney health and function has been difficult to prove and is not yet established by scientific 
evidence. 
Bis(monoacylglycerol)phosphate (BMP) is an atypical phospholipid localized mainly at the inner 
membrane of lysosomes, where its negative charge (due to the acidic pH) helps adherence of 
positively charged polycationic enzymes and activator proteins, thereby promoting 
hydrolysis/degradation [105]. Importantly for a translational aspect, the tissue phospholipidosis 
marker di-22:6-BMP [90, 106] was increased in urine specimens of individuals affected by CKD and 
This article is protected by copyright. All rights reserved.
MetS, and urinary BMP levels positively correlated with albuminuria rates within the group of 
patients with obesity, dyslipidemia and CKD. Furthermore, BMP was shown to colocalize with 
intracellular phospholipidosis and vacuolization sites and lysosomes in murine/human PTEC. Future 
studies with larger cohorts would aid assessment of the potential of urinary di-22:6-BMP as a 
prognostic marker for MetS/obesity-mediated renal disease. 
Inflammation and fibrosis are hallmarks of progressive renal disease [107]. In kidneys, MCP-1 was 
found to be increased as early as one week after initiation of high fat diet feeding [108]. This 
together with our in vitro findings (48h-treatment with U18666A, oxLDL, or 7-KC) suggests that 
proximal TEC can produce this chemokine at a very early stage upon metabolic challenge, possibly 
contributing to the macrophage infiltration observed in WD-fed mice. The induction of fibrotic 
markers in the kidney in the context of hypercaloric diet was previously reported [108-111]. 
Interestingly, the upregulation of SREBPs has a role in kidney fibrosis development, as shown by 
studies with SREBP-1c-deficent mice and SREBP-1a transgenic mice [12, 112]. Importantly, a recent 
report highlights the role of lysosomes and autophagy in renal lipotoxicity [113], while another 
reports enlarged vacuoles and multilamellar inclusions within PTEC following high fat diet [110]. We 
show that a high-cholesterol WD provokes equal pathological alterations in proximal tubules. 
Among the lipids found accumulated in kidneys after WD feeding, the sphingolipid ceramide and its 
metabolites, such as ceramide-1-phosphate (C1P) and sphingosine, warrant particular attention, due 
to their pro-inflammatory properties, which may favour renal inflammation [114, 115]. 
Altogether, our study shows that phospholipidosis in kidneys is a novel pathological pathway in 
obesity-related kidney disease and brings attention to the lysosomal compartment of renal tubules 
as potential target site for intervention/preventive approaches against MetS-induced nephropathy. It 
provides a rationale for screening individuals with obesity or metabolic syndrome, for kidney 
This article is protected by copyright. All rights reserved.
dysfunction and phospholipidosis, e.g. with proton magnetic resonance spectroscopy [116], to 
identify early-stage CKD patients, who can still profit from changes in diet, lifestyle and lipid-lowering 
therapies. 
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Figure legends 
 
Figure 1. Accumulation of polar lipids (phospholipids) and free cholesterol in murine proximal tubular 
epithelial cells upon Western-type diet feeding. (A) PAS-D-stained renal sections of mice fed a control 
diet (CD) or Western-type diet (WD), 20 × magnification. (B) Quantification of tubular vacuolization in 
PAS-D-stained kidney sections of CD- and WD-fed mice: number of vacuolized tubules per high-
power field (HPF, 20 ×). (C) Perilipin-2 staining in CD and WD kidneys sections (20 × magnification, 
100 × magnification far-right image). (D) Nile red and (E) Filipin staining of renal sections for 
detection of phospholipids and free cholesterol, respectively, in kidneys of CD- and WD-fed mice (D 
and E: 20 × and 40 × magnification, respectively). (F) Lipidomics analysis (ESI-MS/MS) of renal lipid 
content: free-cholesterol (FC), cholesterol-esters (CE), fatty acids (FA), bismonoacylglycerophosphate 
(BMP), phosphatidylglycerol (PG), lysophosphatidylglycerol (LPG), phosphatidic acid (PA), cardiolipin 
(CL), sphingomyelin (SPM), ceramide, ceramide-1-phosphate (Cer-1-P), lactosylceramide (LacCer), 
glucosylceramide (GluCer), sphingosine, sphinganine, phosphatidylcholine (PC), 
lysophosphatidylcholine (LPC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), 
phosphatidylserine (PS), plasmogens. (B, F) Data shown as mean ± s.e.m.; *P<0.05, ***P<0.001. 
 
Figure 2. Features of acquired lysosomal storage disease in kidneys exposed to metabolic 
overloading. (A) Transmission electron microscopy (TEM) images of control diet (CD) and Western-
type diet (WD) murine kidneys (upper panel): L, luminal space, MLB, multilamellar bodies, N, nucleus, 
scale bar 10/2 µm. Staining for LIMP-2 and CD63 in CD and WD kidneys sections (20 × magnification, 
40 × magnification far-right column). (B) Images of renal sections of WD-fed mice stained for p62 (40 
× magnification; asterisk= positive vacuolar membrane) and of GFP-LC3/LIMP-2 double-stained 
kidney sections from GFP-LC3 transgenic mice upon WD feeding (100 × magnification; LIMP-2 = red; 
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GFP = blue, asterisk = co-localization, purple). (C) Counts of GFP-LC3 puncta per proximal tubule in CD 
and WD kidneys. (D) mRNA expression of genes related to lysosome function (left graph) and 
lipogenic pathways (right graph) in laser-dissected vacuolar tubules and respective controls from 
mice fed a WD and CD, respectively. Values normalized to control. (E) Positive staining for LDLR, 
oxidized lipoproteins (oxLP) and lipoproteins (LP) in kidneys of WD-fed mice (20 × magnification). 
Data shown as mean ± s.e.m.; *P<0.05, **P<0.01, ***P<0.001. 
 
Figure 3. Proteomics analysis of MLBs isolated from murine kidneys and urine upon metabolic 
overloading. (A) TEM analysis of urine of mice on Western-type diet (WD); scale bars 10/2 µm. (B) 
Western blot for detection of exosome marker Flotillin-2 in total cell lysates and cell-derived 
supernatant in control and U18666A-treated immortalized murine tubular epithelial cells (IMM-
PTEC). (C) Most abundant proteins found in MLBs isolated from both kidney tissue and urine of WD-
fed mice and U18666A-treated IMM-PTEC. Proteins shown after selecting the 50 proteins with the 
highest ppm (relative LC-MS abundance) independently in the protein list derived from proteomic 
analysis of kidney, urine and IMMP-TEC MLBs. (D) Graph showing the frequency of protein origin 
among all intracellular organelles and extracellular exosomes. The proteins considered for analysis 
are the most abundant proteins shown in (C). 
 
Figure 4. Hierarchical cluster and frequency analysis to compare the proteomic profiles of murine 
kidney MLBs (our data), lysosome-related organelles (LROs) [78], lung MLBs [76], epidermis MLBs 
[77], lipid droplets (Lds) from enterocytes [79], adipocytes [80], and hepatocytes [81]. 
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Figure 5. Interference with cholesterol trafficking and oxysterol treatment are responsible for MLB 
formation, disruption of lysosome homeostasis and induction of genes regulating cholesterogenesis. 
(A) TEM images showing the formation of MLBs after in vitro incubation of immortalized murine 
tubular epithelial cells (IMM-PTEC) with U18666A, oxidized low density lipoproteins (oxLDL), and 
oxysterol 7-ketocholesterol (7-KC). Asterisks indicate cellular MLBs localization. (B) Fluorescence 
microscopy (FM) images, in which phospholipidosis and LIMP-2 are detected in control and IMM-
PTEC cells stimulated with U18666A/oxLDL/7KC; nuclei = blue, phospholipidosis = red, LIMP-2 = 
green, co-localization = yellow; 100 × magnification. (C) Increase of lysosomal pH after incubation of 
IMM-PTEC with U18666A, oxLDL, 7KC, and chloroquine (CQ, positive controls). (D) FM images of 
control and U18666A-stimulated human PTEC HK2 cells, showing cellular accumulation of 
phospholipids, cholesterol (filipin staining) and BMP; nuclei = blue, phospholipidosis = red, 
cholesterol = blue, BMP = green; 10 × magnification. (E) FM images of U18666A-stimulated HK2 cells, 
showing phospholipidosis and BMP distribution; nuclei = blue, phospholipidosis = red, BMP = green, 
co-localization = yellow; 100 × magnification. (F) Gene expression of the transcription factor Srebp2, 
its target genes Ldlr and Hmgcr, and lysosomal phospholipase A2 (Lpla2) in control and U18666A-
stimulated IMM-PTEC. Values normalized to control. Data shown as mean ± s.e.m.; *P<0.05, 
**P<0.01, ***P<0.001. 
 
Figure 6. Diet-mediated lipid overload of tubular cells associates with an inflammatory milieu, 
collagen deposition, and reduced specialized transporter expression. (A) Immunostaining of renal 
sections from control diet (CD)- and Western-type diet (WD)-fed mice for visualization of the apical 
SGLT2 transporter, tubular damage marker KIM-1, macrophage infiltration, and collagen type III 
deposition; 20 × magnification. (B, C) Quantitative gene expression analysis for membrane 
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transporters (SGLT2, ATP1A1), chemokine MCP-1, damage marker KIM-1, fibrogenic markers TGF-β 
and CTGF in (B) murine renal tissues and (C) IMM-PTEC. Values normalized to control. (D) Electrolyte 
concentration (sodium, potassium and chloride) in urine of mice fed CD or WD; values normalized for 
urinary creatinine (nmol/mmol). (E) Representative images of renal biopsy from obese 
hypercholesterolaemic patients. Conventional staining with acidophilic dye toluidine blue (left upper 
image) and immunostaining for LIMP-2 revealing the presence of vacuoles within proximal tubular 
cells and the expression of LIMP-2 at the vacuolar membrane, respectively; 20 × magnification. 
Immunofluorescence for visualization of the lysosomal glycerophospholipid BMP within TEC; 100 × 
magnification. TEM images of human tubular cells harbouring MLBs (indicated by asterisks), scale bar 
5 and 1 µm. (F) Quantitative lipidomics analysis: di-docosahexaenoyl (22:6) bis(monoacylglycerol) 
phosphate (di-22:6-BMP) content in human urine specimens; n = 21. (G) Spearman correlation 
between total albumin and di-22:6-BMP urinary concentrations; human urine specimens; n = 21. 
Data shown as mean ± s.e.m.; *P<0.05, **P<0.01, ***P<0.001. 
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